Challenges and Victories for World Hepatitis Day 2026 | | | | |
In observance of World Hepatitis Day, Chari A. Cohen, DrPH, MPH, president of the Hepatitis B Foundation, reflected on the challenges we faced over the past 12 months in the global fight against hepatitis B.
Despite significant hurdles and political headwinds, the past year brought breakthroughs, including promising trial results for GSK’s hepatitis B functional cure candidate, bepirovirsen, and FDA approval for Gilead’s Hepcludex to treat hepatitis D.
Read the full article in HepMag.com to learn about the continued efforts to eliminate hepatitis.
| | Our response to proposed changes in childhood immunization schedules | | |
The proposed changes in childhood immunization schedules announced Aug. 11 raise great concern about its potential impact on U.S. public health and confidence in evidence-based vaccine recommendations.
Access to vaccines is about more than just insurance coverage. It includes access to timely, accurate information that can help parents make the best decisions for their children and their families. The proposed changes in childhood vaccination schedules undermines that access and threatens decades of well-established trust between the American public, their healthcare providers, and the scientists, researchers, and public health professionals who have dedicated their careers to ensuring the safety of vaccines.
For more information about the hepatitis B vaccine, visit www.hepb.org.
| | |
National Immunization Awareness Month:
Protecting communities through hepatitis B vaccination
| | Announcing the 2026 TCS New York City Marathon #Run4HepB Team | | The Hepatitis B Foundation has been selected as an Official Charity Partner for the 2026 TCS New York City Marathon, which has become one of our best means for raising funds to support the fight against hepatitis B. | | |
Meet the #Run4HepB Team
Please join us in cheering on runners who are stepping up to make every step count:
|
- Aaron Rak
- Bharat Dixit
- Callum Clifford
- Emma Thomson
- Jennifer Banz
- Juliana Kugelmas
- Lou Kassa
- Ryan DiLeva
| | | | 7th Annual Hepatitis B Community Forum | | |
The 2026 Hepatitis B Community Forum will be held on Sept. 6 in Singapore, just prior to the opening of the International HBV Meeting. This unique, free event brings together scientists, public health professionals and people living with hepatitis B and D to exchange knowledge, share lived experiences and strengthen collaboration in the fight against HBV.
The goal of this event is to foster communication and community engagement that help drive progress toward a cure and eliminate stigma and discrimination.
Registration is required to attend the Community Forum, please register here.
| | *If you are unable attend in person, a recording of the event will be shared on our website. | | | B Informed Hepatitis Delta Patient Conference | | |
The Hepatitis B Foundation is hosting a B Informed Hepatitis Delta Patient Conference, a free online event on Sept. 22, from 1 pm – 5 pm EDT.
The conference will bring together people with lived experience of hepatitis B and or hepatitis delta, caregivers, community organizations, advocates and health care providers to engage in conversations and collaborate towards changing the story of hepatitis delta.
Registration is required. Please use this Link to register.
| | | New release: Africa CDC hepatitis B operational toolkit | | | | |
The Africa CDC Hepatitis B Operational Toolkit has officially been released, developed in collaboration with a group of experts from across the continent.
Launched in recognition of World Hepatitis Day, this toolkit translates WHO guidelines into practical, real-world applications designed for healthcare providers across all levels of care. To make these guidelines even more accessible and user-friendly, a mobile application is also available to support clinicians on the ground.
You can learn through the Africa CDC Announcement or directly at HEPSA Net.
| | Share your story: Join the Foundation's storytelling project | | |
Your story has the power to change the world.
The Hepatitis B Foundation is looking for new storytellers to participate in our upcoming storytelling project workshop. This workshop is designed to bring together individuals living with or affected by hepatitis B to learn how to effectively share their personal journeys. Learn how to: Educate the public, raise awareness and inspire policy change.
To learn about this project and submit your application, visit our website here.
| | | Follow us on TikTok: @hepbfoundation | | | | |
The Hepatitis B Foundation is officially on TikTok! We are taking our mission to a whole new platform to share health education, dispel common hepatitis B myths, highlight powerful patient stories and give you a behind-the-scenes look at our advocacy work.
Whether you're looking for quick public health facts or want to help us spread awareness to a younger global audience, we’d love to have your support.
👉 Follow @hepbfoundation on TikTok and join the conversation today!
| | Help us improve hepatitis B care & treatment access in Africa | | The African Hepatitis B Advocacy Coalition (ABAC), a program of the Hepatitis B Foundation, is launching a crucial survey to better understand the current landscape of hepatitis B care, challenges in accessing treatment, and areas where we can make a real difference. This will inform global and national strategies to improve equitable access to treatment. | The survey is available in English and French. | | | Share your voice on the Foundation's quality-of-life survey | | | | |
The Hepatitis B Foundation is seeking participants for a new research study titled HepB PROACTive (Hepatitis B: Patient-Reported Outcomes, Adherence and Quality-of-Life Tracking).
The goal of this program is to better understand the daily experiences, treatment challenges and overall well-being of individuals living with chronic hepatitis B.
We're seeking adults age 18+ with hepatitis B living anywhere in the world.
| | New podcast: Navigating hepatitis B and delta through pregnancy | | | | |
In this episode, we spoke with Dr. Tatyana Kushner, associate professor of medicine in the Department of Gastroenterology at Weill Cornell Medicine. Dr. Kushner discusses hepatitis B treatment during pregnancy, including when antiviral therapy is recommended to help prevent mother-to-child transmission, and the importance of continuing hepatitis B care and treatment after pregnancy to support long-term liver health.
Listen to the latest episode of the B Heppy podcast.
| | New blog: New hepatitis delta drug, Hepcludex, now approved in the U.S. | | Please read the full blog here. | | |
We are sharing a historic milestone in the fight against viral hepatitis: Hepcludex (bulevirtide) has officially received FDA approval, making it the first and only approved treatment for chronic hepatitis delta in the U.S.
Now it's time to expand testing for hepatitis delta! With an effective treatment finally available, identifying infections early is more important than ever. If you're living with hepatitis B, please speak to a health care provider about getting tested for hepatitis delta.
| | New training module: Funding the fight against hepatitis | | | | |
Obtaining resources is one of the biggest hurdles in the global effort to eliminate viral hepatitis.
To help you meet this challenge, the Hepatitis B Foundation has launched a new, free online course: Funding the Fight Against Hepatitis, intended for advocates, health care professionals or staff with community organizations.
| | | Aug. 26
3 p.m. EDT | 1 p.m. MT | 9 a.m. HT
Register here | Webinar: Understanding the HepB Birth Doses' impact on series completion amid declining infant HepB Vaccination rates | | Sept. 6
1 - 2:30 p.m. SGT | Community Forum at the 2026
International HBV Meeting, Singapore | | Sept. 6-10 | International HBV Meeting, Singapore | | Sept. 22
1 pm – 5 pm EDT
Register here | Online: B Informed Hepatitis Delta Patient Conference | | | Journal article of the month | |
Socioecological barriers interrupting hepatitis B and
liver cancer care engagement among USA immigrant groups
Academia Oncology
April 10, 2026
https://doi.org/10.20935/AcadOnco8246
Zovich B, Borondy-Jenkins F, Block SJ, Koirala S, Chen T, Moraras K, & Cohen C
[Note: The authors are primarily Hepatitis B Foundation staff and leadership.]
This research examined "the multidimensional factors spanning the top levels of the socioecological model of health (SEM) that influence these (immigrant) communities’ complete engagement in the hepatitis B cascade of care." The team conducted focus groups and interviews with individuals from 13 different highly impacted communities across the U.S.
Their research demonstrated the role and intersection of different SEM constructs in increasing screening, prevention and management of hepatitis B and hepatocellular carcinoma. Participants most often identifies cost of health care, complex care systems, lack of insurance, limited health literacy and cultural differences as barriers to care.
The authors concluded, "Based on study findings, various recommendations, ranging from systemic health policies to community-led initiatives, are proposed to alleviate the significant health disparities caused by hepatitis B and (liver cancer) in these communities.
| |
The Hepatitis B Foundation is a nonprofit organization working around the world to improve the lives of those affected by hepatitis B, hepatitis D and liver cancer; drive prevention, diagnosis and treatment and accelerate scientific research to achieve cures. | | | Learn more about our research and education programs at www.hepb.org | | | | | | |